HeartSciences (HSCS) Return on Capital Employed (2022 - 2025)
HeartSciences' (HSCS) quarterly Return on Capital Employed came in at 177.18% in Q4 2025, down 1771.0% YoY from 10.6% in Q4 2024, and up 49.67% on a QoQ basis from 352.01% in Q3 2025.
HeartSciences (HSCS) Return on Capital Employed (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has 4 years of Return on Capital Employed data on file, last reported at 177.18% in Q4 2025.
- Quarterly Return on Capital Employed fell 1771.0% year-over-year to 177.18% in Q4 2025, while the trailing twelve-month figure through Oct 2025 was 177.18% (down 1771.0% YoY) and the FY2025 annual result came in at 264.34%, down 12854.0% from the prior year.
- Return on Capital Employed grew to 177.18% in Q4 2025, from 352.01% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 554.21% in Q4 2023 to a low of 662.81% in Q2 2025.
- A 4-year average of 226.7% and a median of 250.65% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed surged 86370 bps — and 2024, when it sank 71368 bps.
- Tracing HSCS's Return on Capital Employed over 4 years: stood at 309.49% in 2022, then soared by 279 bps to 554.21% in 2023, then tumbled by 129 bps to 159.47% in 2024, then retreated by 11 bps to 177.18% in 2025.
- The last three Return on Capital Employed figures came in at 177.18% (Q4 2025), 352.01% (Q3 2025), and 662.81% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 12.08% |
| 10 | HeartSciences | 6.64 Mn | 4.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -177.18% |
| Jul 31, 2025 | -352.01% |
| Apr 30, 2025 | -662.81% |
| Jan 31, 2025 | -262.27% |
| Oct 31, 2024 | -159.47% |
| Jul 31, 2024 | -94.07% |
| Apr 30, 2024 | -75.07% |
| Jan 31, 2024 | -123.49% |
| Oct 31, 2023 | 554.21% |
| Jul 31, 2023 | -575.60% |
| Apr 30, 2023 | -394.16% |
| Jan 31, 2023 | -303.36% |
| Oct 31, 2022 | -309.49% |
| Jul 31, 2022 | -239.03% |